Results 41 to 50 of about 56,585 (263)
Rapid and stain-free quantification of viral plaque via lens-free holography and deep learning [PDF]
Nature Biomedical Engineering (2023), 2022 We present a rapid and stain-free quantitative viral plaque assay using lensfree holographic imaging and deep learning. This cost-effective, compact, and automated device significantly reduces the incubation time needed for traditional plaque assays while preserving their advantages over other virus quantification methods.
arxiv +1 more source
Pharmaceutics, 2022 Varicella zoster virus (VZV) causes two diseases: varicella upon primary infection and herpes zoster when latent viruses in the sensory ganglia reactivate.
Ning Luan +4 more
doaj +1 more source
Status of Herpes Zoster and Herpes Zoster Vaccines in 2023: A position paper
Revista Española de Quimioterapia, 2023 Herpes zoster infection (HZ) is an important public health problem due to its high incidence and frequent complications, especially post-herpetic neuropathy . The incidence of HZ increases with age and is more frequent in immunocompromised patients. It is estimated that at least 60,000 people develop HZ each year in Spain.
García, José María Molero +14 more
openaire +2 more sources
Transplantation, 2021 Supplemental Digital Content is available in the text. Background. Immunization of varicella-zoster virus (VZV)-seronegative solid organ transplant (SOT) patients using the live-attenuated varicella vaccine is generally contraindicated, leaving no widely
MD Arnaud G. L'Huillier +11 more
semanticscholar +1 more source
The Journal of Infectious Diseases, 2018 Immunization for herpes zoster (HZ) aims to reverse the decline in cell-mediated immunity to varicella zoster virus that occurs with advancing age or immunocompromise. There are 2 vaccines available, one live attenuated (Zoster vaccine, live attenuated [ZVL]) and, recently, a recombinant subunit vaccine (HZ/su).The literature relevant to the two HZ ...
Anthony L. Cunningham, Myron J. Levin
openaire +3 more sources
Avoiding rash decisions about zoster vaccination: insights from cost-effectiveness evidence
BMC Medicine, 2018 de Boer and colleagues present a cost-effectiveness analysis based in the Netherlands of two vaccines available for the prevention of herpes zoster. Zostavax® was the first vaccine available for the prevention of herpes zoster in older adults.
Chester B. Good +2 more
doaj +1 more source
Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status [PDF]
Human Vaccines & Immunotherapeutics, 2015 Options for managing herpes zoster (HZ)-related pain and complications have limited effectiveness, making HZ prevention through vaccination an important strategy. Limited data are available on HZ vaccine effectiveness against confirmed HZ and manifestations of HZ among vaccinated persons.
Peter C. Wollan +7 more
openaire +3 more sources
Human Vaccines & Immunotherapeutics, 2020 Herpes zoster (shingles) is a painful condition resulting from reactivation of latent varicella zoster virus (VZV). The Australian National Shingles Vaccination Program (commenced November 2016) provides free herpes zoster vaccination for eligible adults
John Litt +8 more
doaj +1 more source
Co-evolution of Vaccination Behavior and Perceived Vaccination Risk can lead to a Stag-Hunt like Game [PDF]
, 2022 Voluntary vaccination is effective to prevent infectious diseases from spreading. Both vaccination behavior and cognition of the vaccination risk play important roles in individual vaccination decision making. However, it is not clear how the co-evolution of the two shapes the population-wide vaccination behavior.
arxiv +1 more source
The Korean Journal of Pain, 2020 Postherpetic neuralgia (PHN) is a challenging condition for pain management specialists. The prevention of herpes zoster (HZ) and subsequent PHN in individuals aged 50 years and older, via the development of new vaccines, is an ongoing research project ...
Grisuna Singh +4 more
semanticscholar +1 more source